Correlation and Heterogeneity of the Immune Microenvironment and Histopathological Growth Patterns in Resectable Colorectal Cancer Liver Metastases
NCT07564908 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 64
Last updated 2026-05-04
Summary
Correlation and Heterogeneity of the Immune Microenvironment and Histopathological Growth Patterns in Resectable Colorectal Cancer Liver Metastases
Conditions
- Colorectal Neoplasms
Interventions
- OTHER
-
Formalin-fixed, paraffin-embedded (FFPE) sections of colorectal cancer liver metastases were stained with hematoxylin and eosin (H&E) and Multiplex immunohistochemistry (mIHC) staining.
Formalin-fixed, paraffin-embedded (FFPE) sections of colorectal cancer liver metastases were stained with hematoxylin and eosin (H\&E) and Multiplex immunohistochemistry (mIHC) staining.
Sponsors & Collaborators
-
Meng Qiu
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2030-12-30
- Completion
- 2030-12-30
Countries
- China
Study Locations
More Related Trials
-
Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer
NCT07269912 ·Status: NOT_YET_RECRUITING
-
Surgery Following Immune Checkpoint Inhibitions for Controlled Disease in Recurrent or Metastatic dMMR/MSI-H Colorectal Cancer
NCT06717763 ·Status: COMPLETED
-
Impact of Environmental Factors and Metabolomics on Colorectal Cancer.
NCT06643429 ·Status: ACTIVE_NOT_RECRUITING
-
Mechanism and Process Regulation for Colorectal Tumors
NCT04707482 ·Status: UNKNOWN
-
A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA
NCT03679039 ·Status: UNKNOWN
-
Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer
NCT07486492 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Comparison of Expression of Carcinogenesis-related Molecular Markers in the Patients With Colon Cancer and Polyp
NCT05638542 ·Status: ACTIVE_NOT_RECRUITING
-
Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis
NCT02979795 ·Status: UNKNOWN
-
Local Liver Treatment for Multi-organ Colorectal Cancer Metastases
NCT06449937 ·Status: RECRUITING ·Phase: NA
-
Deep Learning-Based Analysis of Colorectal Cancer Pathology Images: An Innovative Approach for Predicting Colorectal Cancer Subtypes
NCT06936098 ·Status: COMPLETED
-
The mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and Survival
NCT04482608 ·Status: COMPLETED
-
Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer
NCT06849362 ·Status: ENROLLING_BY_INVITATION
-
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
NCT05797077 ·Status: RECRUITING ·Phase: PHASE3
-
Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation
NCT03135652 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer
NCT02523495 ·Status: UNKNOWN
-
Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection
NCT05720559 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Mechanisms of Fate Evolution of Colorectal Adenocarcinoma Metastasis
NCT04714814 ·Status: UNKNOWN
-
Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
NCT06557668 ·Status: RECRUITING
-
Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer
NCT05635149 ·Status: UNKNOWN
-
Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis
NCT02453490 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases
NCT06504901 ·Status: NOT_YET_RECRUITING
-
Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
NCT07154173 ·Status: RECRUITING
-
Patient-derived Organoids Predicts the Clinical Efficiency of Colorectal Liver Metastasis
NCT05183425 ·Status: UNKNOWN
-
Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases
NCT04525326 ·Status: UNKNOWN ·Phase: PHASE3
-
Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients
NCT03829852 ·Status: COMPLETED